AFP and hepatocellular carcinoma: The most commonly used serum marker of HCC is AFP, which has a reported sensitivity of 39% to 65% and specificity of 65% to 94%; approximately one-third of early-stage HCC patients with small tumors (<3 cm) have normal levels of AFP [2], [7].